Skip to main content

Advertisement

Log in

Function of COX-2 and Prostaglandins in Neurological Disease

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Induction of COX-2 expression and enzymatic activity promotes neuronal injury in a number of models of neurological disease. Inhibition of COX-2 activity, either genetically or pharmacologically, has been shown to be neuroprotective in rodent models of stroke, Parkinson’s disease, and amyotrophic lateral sclerosis. Inhibition of COX activity with nonsteroidal anti-inflammatory drugs (NSAIDs) reduces inflammation and amyloid accumulation in murine transgenic models of Familial Alzheimer’s disease, and the use of NSAIDs decreases the risk of developing Alzheimer’s disease in healthy aging populations. COX-mediated neuronal injury is presumed be due to downstream effects of one or more prostaglandin products including PGE2, PGD2, PGF, PGI2 (prostacylin) and TXA2 (thromboxane) that effect cellular changes through activation of specific prostaglandin receptor subtypes and second messenger systems. In this proceeding, we review recent data demonstrating effects of prostaglandin signaling on neuronal viability that are paradoxically protective, when taken in the context that COX-2 induces neuronal injury in the setting of excitotoxicity. Conversely, in the context of an inflammatory stimulus, the EP2 receptor enhances neuronal injury. These findings argue for an additional level of complexity in the prostaglandin response in neurological disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Abe, H., Takeshita, T., Nagata, K., Arita, T., Endo, Y., Fujita, T., et al. (1999). Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family. Gene, 227, 71–77.

    Article  PubMed  CAS  Google Scholar 

  • Adams, J., Collaco-Moraes, Y., & de Belleroche, J. (1996). Cyclooxygenase-2 induction in cerebral cortex: An intracellular response to synaptic excitation. Journal of Neurochemistry, 66, 6–13.

    Article  PubMed  CAS  Google Scholar 

  • Akaike, A., Kaneko, S., Tamura, Y., Nakata, N., Shiomi, H., Ushikubi, F., et al. (1994). Prostaglandin E2 protects cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity. Brain Research, 663, 237–244.

    Article  PubMed  CAS  Google Scholar 

  • Andreasson, K. I., Savonenko, A., Vidensky, S., Goellner, J. J., Zhang, Y., Shaffer, A., et al. (2001). Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. Journal of Neuroscience, 21, 8198–8209.

    PubMed  CAS  Google Scholar 

  • Bensimon, G., Lacomblez, L., & Meininger, V. (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. New England Journal of Medicine, 330, 585–591.

    Article  PubMed  CAS  Google Scholar 

  • Bilak, M., Wu L., Wang, Q., Haughey, N., Conant, K., St Hillaire, C., et al. (2004). PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Annals of Neurology, 56, 240–248.

    Article  PubMed  CAS  Google Scholar 

  • Breder, C. D., Dewitt, D., & Kraig, R. P. (1995). Characterization of inducible cyclooxygenase in rat brain. Journal of Comparative Neurology, 355, 296–315.

    Article  PubMed  CAS  Google Scholar 

  • Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001). Prostanoid receptors: subtypes and signaling. Annual Review of Pharmacology and Toxicology, 41, 661–690.

    Article  PubMed  CAS  Google Scholar 

  • Carlson, N. G. (2003). Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid. Journal of Neuroscience Research, 71, 71–88.

    Article  CAS  Google Scholar 

  • Cazevielle, C., Muller, A., Meynier, F., Dutrait, N., & Bonne, C. (1994). Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochemistry International, 24, 156–159.

    Google Scholar 

  • Chen, C., Magee, J. C., & Bazan, N. G. (2002). Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. Journal of Neurophysiology, 87, 2851–2857.

    PubMed  CAS  Google Scholar 

  • Dore, S., Otsuka, T., Mito, T., Sugo, N., Hand, T., Wu, L., et al. (2003). Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Annals of Neurology, 54, 155–162.

    Article  PubMed  CAS  Google Scholar 

  • Drachman, D. B., Frank, K., Dykes-Hoberg, M., Teismann, P., Almer, G., Przedborski, S., et al. (2002). Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Annals of Neurology, 52, 771–778.

    Article  PubMed  CAS  Google Scholar 

  • Feng, Z. H., Wang, T. G., Li, D. D., Fung, P., Wilson, B. C., Liu, B., et al. (2002). Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neuroscience Letters, 329, 354–358.

    Article  PubMed  CAS  Google Scholar 

  • Govoni, S., Masoero, E., Favalli, L., Rozza, A., Scelsi, R., Viappiani, S., et al. (2001). The cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neuroscience Letters, 303, 91–94.

    Article  PubMed  CAS  Google Scholar 

  • Hata, A. N., Zent, R., Breyer, M. D., & Breyer, R. M. (2003). Expression and molecular pharmacology of the mouse CRTH2 receptor. Journal of Pharmacology and Experimental Therapeutics, 306, 463–470.

    Article  PubMed  CAS  Google Scholar 

  • Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., et al (2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. Journal of Experimental Medicine, 193, 255–261.

    Article  PubMed  CAS  Google Scholar 

  • Hirata, M., Kakizuka, A., Aizawa, M., Ushikubi, F., & Narumiya, S. (1994). Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proceedings of the National Academy of Sciences of the United States of America, 91, 11192–11196.

    Article  PubMed  CAS  Google Scholar 

  • Kaufmann, W. E., Andreasson, K. I., Isakson, P. C., & Worley, P. F. (1997). Cyclooxygenases and the central nervous system. Prostaglandins, 54, 601–624.

    Article  PubMed  CAS  Google Scholar 

  • Kaufmann, W. E., Worley, P. F., Pegg, J., Bremer, M., & Isakson, P. (1996). Cox-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proceedings of the National Academy of Sciences of the United States of America, 93, 2317–2321.

    Article  PubMed  CAS  Google Scholar 

  • Lacomblez, L., Bensimon, G., Leigh, P. N., Guillet, P., & Meininger, B. for the Amyotrophic Lateral Sclerosis Study Group II (1996). Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet, 347, 1425–1431.

    PubMed  CAS  Google Scholar 

  • Liang, X., Wang, Q., Hand, T., Wu, L., Breyer, R. M., Montine, T. J., et al. (2005a). Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer’s disease. Journal of Neuroscience, 25, 10180–10187.

    Article  PubMed  CAS  Google Scholar 

  • Liang, X. B., Wu, L. J., Hand, T., & Andreasson, K. (2005b). PGD2 mediates a neuroprotective effect via the DP1 receptor. Journal of Neurochemistry, 92, 477–485.

    Article  PubMed  CAS  Google Scholar 

  • Liu, D., Wu, L., Breyer, R., Mattson, M. P., & Andreasson, K. (2005). Neuroprotection mediated by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Annals of Neurology, 57, 758–761.

    Article  PubMed  CAS  Google Scholar 

  • McCullough, L., Wu, L., Haughey, N., Liang, X., Hand, T., Wang, Q., et al. (2004). Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. Journal of Neuroscience, 24, 257–268.

    Article  PubMed  CAS  Google Scholar 

  • Miettinen, S., Fusco, F. R., Yrjanheikki, J., Keinanen, R., Hirvonen, T., Roivainen, R., et al. (1997). Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2. Proceedings of the National Academy of Sciences of the United States of America, 94, 6500–6505.

    Article  PubMed  CAS  Google Scholar 

  • Monneret, G., Gravel, S., Diamond, M., Rokach, J., & Powell, W. S. (2001). Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood, 98, 1942–1948.

    Article  PubMed  CAS  Google Scholar 

  • Montine, T. J., Milatovic, D., Gupta, R. C., Valyi-Nagy, T., Morrow, J. D., & Breyer, R. M. (2002). Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. Journal of Neurochemistry, 83, 463–470.

    Article  PubMed  CAS  Google Scholar 

  • Nakayama, M., Uchimura, K., Zhu, R. L., Nagayama, T., Rose, M. E., Stetler, R. A., et al. (1998). Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proceedings of the National Academy of Sciences of the United States of America, 95, 10954–10959.

    Article  PubMed  CAS  Google Scholar 

  • Nogawa, S., Zhang, F., Ross, M. E., & Iadecola, C. (1997). Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. Journal of Neuroscience, 17, 2746–2755.

    PubMed  CAS  Google Scholar 

  • Pompl, P. N., Ho, L., Bianchi, M., McManus, T., Qin, W., & Pasinetti, G. M. (2003). A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB Journal, 10, 1096.

    Google Scholar 

  • Prasad, K. N., La Rosa, F. G., & Prasad, J. E. (1998). Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid. In Vitro Cellular and Developmental Biology, Animal, 34, 265–274.

    Article  CAS  Google Scholar 

  • Rothstein, J. D., Jin, L., Dykes-Hoberg, M., & Kuncl, R. W. (1993). Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 90, 6591–6595.

    Article  PubMed  CAS  Google Scholar 

  • Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992). Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. New England Journal of Medicine, 326, 1464–1468.

    Article  PubMed  CAS  Google Scholar 

  • Rothstein, J. D., Tsai, G., Kuncl, R. W., Clawson, L., Cornblath, D. R., Drachman, D. B., et al. (1990). Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Annals of Neurology, 28, 18–25.

    Article  PubMed  CAS  Google Scholar 

  • Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Annals of Neurology, 38, 73–84.

    Article  PubMed  CAS  Google Scholar 

  • Smith, W. L., Marnett, L. J., & DeWitt, D. L. (1991). Prostaglandin and thromboxane biosynthesis. Pharmacology and Therapeutics, 48, 153–179.

    Article  Google Scholar 

  • Takadera, T., Yumoto, H., Tozuka, Y., & Ohyashiki, T. (2002). Prostaglandin E2 induces caspase-dependent apoptosis in rat cortical cells. Neuroscience Letters, 317, 61–64.

    Article  PubMed  CAS  Google Scholar 

  • Teismann, P., Tieu, K., Choi, D. K., Wu, D. C., Naini, A., Hunot, S., et al. (2003). Cyclooxygenase-2 is instrumental in Parkinson’s disease neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America, 100, 5473–5478.

    Article  PubMed  CAS  Google Scholar 

  • Wu, L., Wang, Q., Lians, X., & Andreasson, K. (2007). Divergent effects of prostaglandin receptor signaling on neuronal survival. Neuroscience Letters, 421, 253–258.

    Article  PubMed  CAS  Google Scholar 

  • Yamagata, K., Andreasson, K., Kaufmann, W. E., Barnes, C. A., & Worley, P. F. (1993). Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron, 11, 371–386.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the American Federation for Aging Research Beeson Award (KA), the American Heart Association (LM), AG15799 (KA), CDMRP PR043148 (KA), NS045727 (KA), and the MDA (KA).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Andreasson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liang, X., Wu, L., Wang, Q. et al. Function of COX-2 and Prostaglandins in Neurological Disease. J Mol Neurosci 33, 94–99 (2007). https://doi.org/10.1007/s12031-007-0058-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-007-0058-8

Keywords

Navigation